BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28192402)

  • 21. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.
    Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW
    PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
    Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
    EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
    Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
    Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function.
    Sun N; Zhong X; Wang S; Zeng K; Sun H; Sun G; Zou R; Liu W; Liu W; Lin L; Song H; Lv C; Wang C; Zhao Y
    EBioMedicine; 2020 Dec; 62():103108. PubMed ID: 33186807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans.
    Wang H; Song X; Liao H; Wang P; Zhang Y; Che L; Zhang J; Zhou Y; Cigliano A; Ament C; Superville D; Ribback S; Reeves M; Pes GM; Liang B; Wu H; Evert M; Calvisi DF; Zeng Y; Chen X
    Hepatology; 2021 Jul; 74(1):248-263. PubMed ID: 33368437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1.
    Yao S; Tian C; Ding Y; Ye Q; Gao Y; Yang N; Li Q
    Oncotarget; 2016 Jul; 7(27):42566-42578. PubMed ID: 27302923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma.
    Chang L; Li C; Guo T; Wang H; Ma W; Yuan Y; Liu Q; Ye Q; Liu Z
    J Exp Clin Cancer Res; 2016 Jan; 35():8. PubMed ID: 26759305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-181b-induced SMAD7 downregulation controls granulosa cell apoptosis through TGF-β signaling by interacting with the TGFBR1 promoter.
    Yao W; Pan Z; Du X; Zhang J; Li Q
    J Cell Physiol; 2018 Sep; 233(9):6807-6821. PubMed ID: 29319157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis.
    Zhao Q; Cai W; Zhang X; Tian S; Zhang J; Li H; Hou C; Ma X; Chen H; Huang B; Chen D
    J Biol Chem; 2017 Feb; 292(6):2143-2158. PubMed ID: 28028181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
    Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
    Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.
    Shi JY; Ma LJ; Zhang JW; Duan M; Ding ZB; Yang LX; Cao Y; Zhou J; Fan J; Zhang X; Zhao YJ; Wang XY; Gao Q
    BMC Cancer; 2017 Sep; 17(1):648. PubMed ID: 28903735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
    Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z
    J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
    Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
    Boye A; Kan H; Wu C; Jiang Y; Yang X; He S; Yang Y
    Tumour Biol; 2015 May; 36(5):3643-51. PubMed ID: 25560488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines.
    Gungor MZ; Uysal M; Ozturk M; Senturk S
    J Gastrointest Cancer; 2021 Dec; 52(4):1320-1335. PubMed ID: 34463913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KLF4 suppresses the tumor activity of cutaneous squamous cell carcinoma (SCC) cells via the regulation of SMAD signaling and SOX2 expression.
    Li XM; Kim SJ; Hong DK; Jung KE; Choi CW; Seo YJ; Lee JH; Lee Y; Kim CD
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1110-1115. PubMed ID: 31284949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.